A Population‐Based Study of the Incidence and Molecular Epidemiology of Methicillin‐Resistant Staphylococcus aureus Disease in San Francisco, 2004–2005
The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA) infections have become a major public health problem in both the community and hospitals. Few studies have characterized the incidence and clonal composition of disease-causing strains in an entire population. Our objective was to perform a population-based survey of the clinical and molecular epidemiology of MRSA disease in San Francisco, California. METHODS: We prospectively collected 3985 MRSA isolates and associated clinical and demographic information over a 12-month period (2004-2005) at 9 San Francisco-area medical centers. A random sample of 801 isolates was selected for molecular analysis. RESULTS: The annual incidence of community-onset MRSA disease among San Francisco residents was 316 cases per 100,000 population, compared with 31 cases per 100,000 population for hospital-onset disease. Persons who were aged 35-44 years, were men, and were black had the highest incidence of community-onset disease. The USA300 MRSA clone accounted for 234 cases of community-onset disease and 15 cases of hospital-onset disease per 100,000 population, constituting an estimated 78.5% and 43.4% of all cases of MRSA disease, respectively. Patients with community-onset USA300 MRSA versus non-USA300 MRSA disease were more likely to be male, be of younger age, and have skin and soft-tissue infections. USA300 strains were generally more susceptible to multiple antibiotics, although decreased susceptibility to tetracycline was observed in both community-onset (P = .008) and hospital-onset (P = .03) USA300 compared to non-USA300 strains. CONCLUSIONS: The annual incidence of community-onset MRSA disease in San Francisco is substantial, surpassing that of hospital-onset disease. USA300 is the predominant clone in both the community and hospitals. The dissemination of USA300 from the community into the hospital setting has blurred its distinction as a community-associated pathogen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Outpatient rates of community-associated MRSA infection increased sevenfold over 1999 -2006 in the USA, and subsequently became a signi fi cant cause of MRSA infections within the hospital setting [3, 11].”
From Reduction in community-onset methicillin-resistant Staphylococcus aureus rates in an urban Canadian hospital setting (2014) · cites this paper as [3]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Enright, M. C., Day, N. P. J., Davies, C. E., Peacock, S. J., & Spratt, B. G. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.3.1008-1015.2000 · Cited by 3,063
Self-citationLina, G., Piemont, Y., Godail-Gamot, F., Bes, M., Peter, M.-O., Gauduchon, V., Vandenesch, F., & Etienne, J. (1999) · Clinical Infectious Diseases · doi:10.1086/313461 · Cited by 2,489 · cited 1×
“A total of 801 isolates were selected for sequencing of the protein A gene polymorphic region (spa typing) [29] and PCR testing for ACME [11] and PVL genes [30].”
MethodMethicillin-Resistant S. aureus Infections among Patients in the Emergency Department
Moran, G. J., Krishnadasan, A., Gorwitz, R. J., Fosheim, G. E., McDougal, L. K., Carey, R. B., & Talan, D. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055356 · Cited by 2,285 · cited 3×
“Many studies characterizing community-associated MRSA and the USA300 strain have focused on outbreaks in particular groups [12–16] or among people presenting with skin and soft-tissue infection [7, 17].”
BackgroundNaimi, T. S. (2003) · JAMA · doi:10.1001/jama.290.22.2976 · Cited by 1,688 · cited 5×
“other studies [2, 7, 17, 38], incidence of community-onset MRSA was the highest in a younger age group (35–44 years).”
BackgroundResultInfluentialDiep, B. A., Gill, S. R., Chang, R. F., Phan, T. H., Chen, J. H., Davidson, M. G., Lin, F., Lin, J., Carleton, H. A., Mongodin, E. F., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68231-7 · Cited by 1,633 · cited 6×
“PCR confirmed the presence of the mecA gene in all isolates [33].”
BackgroundMethodInfluentialSelf-citationMethicillin-Resistant Staphylococcus aureus Disease in Three Communities
Fridkin, S. K., Hageman, J. C., Morrison, M., Sanza, L. T., Como-Sabetti, K., Jernigan, J. A., Harriman, K., Harrison, L. H., Lynfield, R., & Farley, M. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043252 · Cited by 1,493 · cited 4×
“1086/587893 MRSA clone has become a primary cause of community-associated disease [2, 7, 8] and an increasingly important source of health care–associated infection [9, 10].”
BackgroundResultInfluentialHerold, B. C. (1998) · JAMA · doi:10.1001/jama.279.8.593 · Cited by 1,412 · cited 1×
“Since the late 1990s, methicillin-resistant Staphylococcus aureus (MRSA) has emerged as a significant pathogen in the community [1–6].”
BackgroundOliveira, D. C., & Lencastre, H. D. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.7.2155-2161.2002 · Cited by 1,343 · cited 1×
“PCR confirmed the presence of the mecA gene in all isolates [33].”
BackgroundShopsin, B., Gomez, M., Montgomery, S. O., Smith, D. H., Waddington, M., Dodge, D. E., Bost, D. A., Riehman, M., Naidich, S., & Kreiswirth, B. N. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.11.3556-3563.1999 · Cited by 984 · cited 1×
“A total of 801 isolates were selected for sequencing of the protein A gene polymorphic region (spa typing) [29] and PCR testing for ACME [11] and PVL genes [30].”
MethodCommunity-acquired meticillin-resistant Staphylococcus aureus: an emerging threat
Zetola, N., Francis, J. S., Nuermberger, E. L., & Bishai, W. R. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70112-2 · Cited by 791
Research works printed but not linked: 3
- Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus infections among competitive sports partici- pants-Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000-2003. MMWR 2003; 52:793-5.
- Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus skin or soft tissue infections in a state prison- Mississippi, 2000. MMWR 2001; 50:919-22.
- Diep BA, Stone GG, Basuino L, et al. The ACME and SCCmec linkage: convergence of virulence and resistance in the USA300 clone of meth- icillin-resistant Staphylococcus aureus. J Infect Dis (in press).
Cited by
Items 101–200 of 205
Tsai, H.-C., Tao, C., Hsu, B., Yang, Y.-Y., Tseng, Y., Huang, T.-Y., Huang, S.-W., Kuo, Y., & Chen, J. (2020) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2020.110724 · Cited by 27
Scott, E. A. (2013) · American Journal of Infection Control · doi:10.1016/j.ajic.2013.05.014 · Cited by 31
Epidemiology and Virulence of Community-Associated MRSA
Kennedy, A. D., & DeLeo, F. R. (2009) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2009.09.004 · Cited by 34
Hudson, L. O., Murphy, C. R., Spratt, B. G., Enright, M. C., Terpstra, L., Gombosev, A., Hannah, P., Mikhail, L., Alexander, R. C., Moore, D. F., et al. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05336-11 · Cited by 29
“Defining the characteristics of MRSA strains in adults and children would provide insight into the spread of MRSA strains, particularly since there is growing evidence that community and health care MRSA reservoirs are mixing (28, 30, 34, 49, 52).”
BackgroundSelf-citationEscalation of antimicrobial resistance among MRSA part 1: focus on global spread
Lynch, J. P., & Zhanel, G. G. (2022) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2023.2154653 · Cited by 29
Thomsen, T. T., Mojsoska, B., Cruz, J. C. S., Donadio, S., Jenssen, H., Løbner‐Olesen, A., & Rewitz, K. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02965-15 · Cited by 27
Alrabiah, K., Alola, S. A., Banyan, E. A., Al-Shaalan, M., & Johani, S. A. (2016) · International Journal of Pediatrics and Adolescent Medicine · doi:10.1016/j.ijpam.2016.03.006 · Cited by 25
Parvez, N., Jinadatha, C., Fader, R., Huber, T. W., Robertson, A., Kjar, D., & Cornelius, L. (2010) · Southern Medical Journal · doi:10.1097/smj.0b013e3181f69235 · Cited by 27
Staphylococcus aureus in Animals
Haag, A. F., Fitzgerald, J. R., & Penadés, J. R. (2019) · ASM Press eBooks · doi:10.1128/9781683670131.ch46 · Cited by 40
Vena, A., Castaldo, N., Magnasco, L., Bavastro, M., Limongelli, A., Giacobbe, D. R., & Bassetti, M. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2022.2161885 · Cited by 25
Simor, A. E., Louie, L., Watt, C., Gravel, D., Mulvey, M. R., Campbell, J., McGeer, A., Bryce, E., Loeb, M. B., & Matlow, A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01717-09 · Cited by 28
A Retrospective Review of Streptococcal Infections in Pediatric Atopic Dermatitis
Sugarman, J. L., Hersh, A. L., Okamura, T., Howard, R., & Frieden, I. J. (2011) · Pediatric Dermatology · doi:10.1111/j.1525-1470.2010.01377.x · Cited by 21
Kim, J., Ferrato, C., Golding, G. R., Mulvey, M. R., Simmonds, K., Svenson, L. W., Keays, G., Chui, L., Lovgren, M., & Louie, M. (2010) · Epidemiology and Infection · doi:10.1017/s0950268810002128 · Cited by 25
Mohamed, S. B., Adlan, T. A., Khalafalla, N. A., Abdalla, N. I., Ali, M. S., Abdella Munir, K. A., Hassan, M. M., & Elnour, M. B. (2019) · Evolutionary Bioinformatics · doi:10.1177/1176934319864945 · Cited by 21
Gill, V. C., Ma, I. W. Y., Guo, M., Gregson, D. B., Naugler, C. T., & Church, D. L. (2019) · BMC Public Health · doi:10.1186/s12889-019-7169-3 · Cited by 24
Chen, Y., Yang, J., Wang, Y., You, J., Zhu, W., Liu, C., Luan, Y., Li, L., & Li, H. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-08631-z · Cited by 19
“USA300 was the most frequently isolated strain in both CA and HA infections [44].”
BackgroundSelf-citationHarrington, A., Mahlen, S. D., & Clarridge, J. E. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01770-09 · Cited by 19
Graber, C. J., Shane, A. L., Weintrub, P. S., & Chambers, H. F. “. (2011) · Pediatric Dermatology · doi:10.1111/j.1525-1470.2011.01508.x · Cited by 19
Self-citationSchneider‐Lindner, V., Quach, C., Hanley, J. A., & Suissa, S. (2011) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpediatrics.2011.143 · Cited by 20
Shimizu, M., Mihara, T., Ohara, J., Inoue, K., Kinoshita, M., & Sawa, T. (2022) · PLoS ONE · doi:10.1371/journal.pone.0271115 · Cited by 18
“USA300 is a CC8, ST8, and lukF-PV gene-positive strain that increased dramatically in the United States in the first half of 2000 [46,47] and was first reported in Japan in 2007 [48].”
BackgroundThe problem of complicated skin and skin structure infections: the need for new agents
Moellering, R. C. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq250 · Cited by 17
In Vivo Activity of the Pyrrolopyrazolyl-Substituted Oxazolidinone RWJ-416457
Hilliard, J. J., Fernandez, J., Melton, J. L., Macielag, M. J., Goldschmidt, R. M., Bush, K., & Abbanat, D. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00833-08 · Cited by 19
“Notably, with increased exposure of CA-MRSA to antibiotics, increasing resistance to tetracyclines and clindamycin has been reported (10, 20 , 31).”
BackgroundTsai, M.-S., Chen, C., Lin, T., & Huang, Y. (2017) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2017.07.014 · Cited by 18
Al-Zubeidi, D. N., Hogan, P. G., Boyle, M., Burnham, C. D., & Fritz, S. A. (2013) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000204 · Cited by 18
Takahashi, Y., Takesue, Y., Takubo, S., Ishihara, M., Nakajima, K., Tsuchida, T., Ikeuchi, H., & Uchino, M. (2013) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-013-0551-7 · Cited by 18
“Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of serious hospital- and community-acquired infections [1–3].”
BackgroundDeLorenze, G. N., Horberg, M. A., Silverberg, M. J., Tsai, A., Quesenberry, C. P., & Baxter, R. P. (2013) · Epidemiology and Infection · doi:10.1017/s0950268813000228 · Cited by 17
Lee, J. Y., Chong, Y. P., Kim, T., Hong, H., Park, S., Lee, E.-S., Kim, M., Kim, S., Lee, S., Choi, S., et al. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku076 · Cited by 16
Vorasin, O., Momphanao, K., Katrun, P., Kuhakarn, C., & Jiarpinitnun, C. (2022) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2022.128652 · Cited by 16
Lemmens, N., van Wamel, W. J. B., Snijders, S. V., Lesse, A. J., Faden, H. S., & van Belkum, A. (2010) · Microbial Pathogenesis · doi:10.1016/j.micpath.2010.12.006 · Cited by 19
Boundy, S., Zhao, Q., Fairbanks, C., Folgosa, L., Climo, M. W., & Archer, G. L. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.01063-11 · Cited by 24
“The MRSA strains colonizing these six patients were SCCmec type II/multilocus sequence type (MLST) CC5/PFGE USA100, the usual health careassociated strain type, in three patients and type IV/CC8/ USA300, the epidemic community-associated strain that is increasingly being seen in nosocomial infections (10), in the rema…”
BackgroundEmergence and Spread of Antimicrobial-Resistant Pathogens in an Era of Globalization
Senok, A. C., Botta, G. A., & Soge, O. O. (2012) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/2012/286703 · Cited by 21
“The clone USA 300 became the predominant strain type in the USA and has spread to Europe, South America, and Australia [347, 349, 350].”
BackgroundEpidemiology of the Staphylococcus aureus CA-MRSA USA300 in Belgium
Argudín, M. Á., Deplano, A., Nonhoff, C., Yin, N., Michel, C., Martiny, D., Keersmaecker, S. C. J. D., & Hallin, M. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-021-04286-3 · Cited by 15
The crisis of antimicrobial resistance: current status and future strategies
Song, J., & Joo, E. (2010) · Journal of Korean Medical Association · doi:10.5124/jkma.2010.53.11.999 · Cited by 16
Reduction of Methicillin-Resistant Staphylococcus aureus Infection among Veterans in Atlanta
Stenehjem, E., Stafford, C., & Rimland, D. (2013) · Infection Control & Hospital Epidemiology · doi:10.1086/668776 · Cited by 14
David, M. Z., Siegel, J. D., Henderson, J., Leos, G., Lo, K., Iwuora, J., Porsa, E., Schumm, L. P., Boyle‐Vavra, S., & Daum, R. S. (2014) · Infection Control and Hospital Epidemiology · doi:10.1086/678606 · Cited by 17
Narayanaswamy, V. P., Giatpaiboon, S., Uhrig, J. P., Orwin, P. M., Wiesmann, W. P., Baker, S., & Townsend, S. M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191522 · Cited by 14
Arcenas, R. C., Spadoni, S., Mohammad, A. A., Kiechle, F. L., Walker, K., Fader, R., Perdreau‐Remington, F., Osiecki, J. C., Liesenfeld, O., Hendrickson, S., et al. (2012) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2012.01.015 · Cited by 13
Self-citationPreventing the introduction of meticillin-resistant Staphylococcus aureus into hospitals
Larsen, J., David, M. Z., Vos, M. D., Coombs, G. W., Grundmann, H., Harbarth, S., Voß, A., & Skov, R. L. (2014) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2014.09.003 · Cited by 13
Pediatricians' perspectives on the impact of MRSA in primary care: a qualitative study
Hersh, A. L., Cabana, M. D., Gonzales, R., Shenkin, B. N., & Cho, C. S. (2009) · BMC Pediatrics · doi:10.1186/1471-2431-9-27 · Cited by 13
COMMENTARY: PREVENTION OF RECURRENT STAPHYLOCOCCAL INFECTIONS
Kaplan, S. L. (2008) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31818632b3 · Cited by 14
Incidence of methicillin resistant Staphylococcus aureus (MRSA) from septicemia suspected children
Saravanan, M. (2009) · Indian Journal of Science and Technology · doi:10.17485/ijst/2009/v2i12.5 · Cited by 12
Sherwood, J. E., Park, M., Robben, P. M., Whitman, T. J., & Ellis, M. W. (2013) · Infection Control and Hospital Epidemiology · doi:10.1086/669866 · Cited by 12
“2 ( 6 ) 10 (33) 19 (63) 7(23) 14 (47) 2 ( 6 )”
Weiss, C. A., Jr., Kaminsky, P., Boggs, J. M., & Ley, C. (2011) · BMC Research Notes · doi:10.1186/1756-0500-4-33 · Cited by 12
Socio-economic profile of patients with community-acquired skin and soft tissue infections in Delhi
Ravishankar, A., Singh, S., Rai, S., Sharma, N., Gupta, S., & Thawani, R. (2014) · Pathogens and Global Health · doi:10.1179/2047773214y.0000000154 · Cited by 12
Community-Associated Methicillin-ResistantStaphylococcus aureusand Athletes
Małachowa, N., Kobayashi, S. D., & DeLeo, F. R. (2012) · The Physician and Sportsmedicine · doi:10.3810/psm.2012.05.1960 · Cited by 14
Have We Outlived the Concept of Commensalism for Staphylococcus aureus?
Proctor, R. A. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1431 · Cited by 14
Distribution of methicillin-resistantStaphylococcus aureusin a low-prevalence area
Moen, A. E. F., Storla, D. G., & Bukholm, G. (2009) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2009.00649.x · Cited by 11
“Today, CA-MRSA appears to have started the replacement of HA-MRSA in hospital settings in certain areas (Carleton et al., 2004; Liu et al., 2008).”
Antimicrobial Resistance in Gram-positive Cocci: Past 50 Years, Present and Future
Song, J. (2011) · Infection and Chemotherapy · doi:10.3947/ic.2011.43.6.443 · Cited by 11
Chen, Y.-J., Liu, K.-L., Chen, C., & Huang, Y. (2015) · Medicine · doi:10.1097/md.0000000000001961 · Cited by 11
Variability of SCCmec in the Zurich area
Ender, M., Bürger, S., Sokoli, A., Zbinden, R., Berger‐Bächi, B., Heusser, R., Senn, M. M., & McCallum, N. (2008) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-008-0663-7 · Cited by 10
“A particularly successful clone is strain USA300, which is spreading at a tremendous rate in the United States [ 15 ].”
BackgroundRehman, T., Aslam, R., Aqib, A. I., Mohsin, M., Manzoor, A. A., Shoaib, M., Naseer, M. A., Hasan, A., Sattar, H., Kulyar, M. F., et al. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104537 · Cited by 9
Huang, V., & Eells, S. J. (2011) · Wiley eBooks · doi:10.1002/9781118063842.ch10 · Cited by 9
Hermos, C., Sandora, T. J., WILLIAMS, L. E., Mosammaparast, N., & McAdam, A. J. (2012) · Epidemiology and Infection · doi:10.1017/s0950268812002476 · Cited by 8
Hersh, A. L., Weintrub, P. S., & Cabana, M. D. (2009) · Academic Pediatrics · doi:10.1016/j.acap.2009.02.002 · Cited by 8
Why Has Methicillin-Resistant Staphylococcus aureus Become Such a Successful Pathogen in Adults?
Dylewski, J. M. (2010) · Infectious Diseases in Clinical Practice · doi:10.1097/01.idc.0000388572.50538.a4 · Cited by 7
Yamaki, J., Lee, M., Shriner, K. A., & Wong‐Beringer, A. (2011) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2010.12.003 · Cited by 5
Herbal Support for Methicillin-Resistant Staphylococcus aureus Infections
Yarnell, E. L., & Abascal, K. (2009) · Alternative and Complementary Therapies · doi:10.1089/act.2009.15402 · Cited by 5
Hsiang, M. S., Chambers, H. F. “., Hermos, C., Shiau, R. L., & Pan, E. (2015) · Journal of Pediatric Infectious Diseases · doi:10.3233/jpi-2009-0169 · Cited by 5
Self-citationWILMER, A., LLOYD-SMITH, E., ROMNEY, M. G., CHAMPAGNE, S., WONG, T., ZHANG, W., STENSTROM, R., & HULL, M. W. (2014) · Epidemiology and Infection · doi:10.1017/s0950268813001568 · Cited by 4
Belinchón, I., Merino, E., & Ramos, J. M. (2025) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2025.107846 · Cited by 4
Prevalence of drug-resistant microbes in sepsis cases of catheter and fistula based haemodialysis
Jiang, R., Ahmed, W., Daud, H., Ahmed, D., Al-Rejaie, S. S., Awais, M., Muhammad, I., Khan, M., Jalal, M. M., Alshehri, O. M., et al. (2021) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2021.08.046 · Cited by 4
Principles of Anti-infective Therapy
Eliopoulos, G. M., & Moellering, R. C. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00017-5 · Cited by 10
Sergi, S., Donnarumma, F., Mastromei, G., Goti, E., Nicoletti, P., Pecile, P., Cecconi, D., Mannino, R., Fanci, R., Bosi, A., et al. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.00624-09 · Cited by 4
Recent Advances in the Discovery and Development of New Drugs Against Gram-Negative Pathogens
(2014) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9781608058549114010008 · Cited by 3
Shurland, S. M., Stine, O. C., Venezia, R. A., Johnson, J. K., Zhan, M., Furuno, J. P., Miller, R. R., Pelser, C. B., & Roghmann, M. (2010) · Infection Control and Hospital Epidemiology · doi:10.1086/655015 · Cited by 3
Dosing strategies to optimize currently available anti-MRSA treatment options (Part 2: PO options)
Payne, K. D., Das, A., Ndiulor, M., & Hall, R. G. (2017) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2018.1411800 · Cited by 3
“For example, by the mid-2000s the rate of community acquired MRSA annually surpassed hospital-acquired MRSA in the San Francisco Bay Area [2].”
BackgroundClinical Manifestations of Community‐Acquired MRSA Infections
Schwartz, B. S., & Chambers, H. F. “. (2009) · Wiley eBooks · doi:10.1002/9781444308464.ch29 · Cited by 3
Self-citationStaphylococcus aureus in Iowa child care facilities
Moritz, E. D. (2010) · doi:10.17077/etd.3ryhs00c · Cited by 3
Kim, T. S., Kim, M. J., Kim, S. H., Kee, H.-Y., Seo, J., Kim, E. S., Moon, Y.-U., Ryu, P. Y., & Ha, D.-R. (2012) · Infection and Chemotherapy · doi:10.3947/ic.2012.44.4.289 · Cited by 2
Changing epidemiology of community-acquired methicillin-resistant Staphylococcus aureus
MOLLAGHAN, A. M. (2011) · British Journal of Biomedical Science · doi:10.1080/09674845.2011.11730345 · Cited by 4
Dosing strategies to optimize currently available anti-MRSA treatment options (Part 1: IV options)
Hall, R. G., Thatcher, M. D., Wei, W., Varghese, S., Varughese, L., Ndiulor, M., & Payne, K. D. (2017) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1300527 · Cited by 2
The Ongoing Threat of Methicillin-Resistant Staphylococcus aureus
Long, S. W. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa260 · Cited by 3
Infection control of Staphylococcus aureus : spa typing to elucidate transmission
Mernelius, S. (2015) · Linköping University medical dissertations · doi:10.3384/diss.diva-116703 · Cited by 2
“The USA300 clone is widely disseminated throughout the USA and accounted for nearly 80 % of the CA-MRSA in a San Francisco-based study (Liu et al. 2008).”
BackgroundDjoudi, F., Benallaoua, S., Bonura, C., Touati, A., & Mammina, C. (2014) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2014.03.001 · Cited by 2
Staphylococcus aureus vaccines
Daum, R. S. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-0090-5.00060-4 · Cited by 3
Lee, D., Eom, S., Lee, M., & Kim, Y. (2013) · Wiley eBooks · doi:10.1002/9783527665259.ch06 · Cited by 2
Keleekai-Brapoh, N. (2011) · doi:10.7916/d8b2829q · Cited by 1
Sahu, A., Parai, D., Choudhary, H. R., & Singh, D. D. (2023) · Current Bioactive Compounds · doi:10.2174/1573407219666230525153419 · Cited by 1
Staphylococcus aureus Vaccines
Thomsen, I. P., & Proctor, R. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79058-1.00056-6 · Cited by 2
A Review on Pathogenesis and Regulatory Mechanisms of Infections from Staphylococcus Aureus
Choudhuri, A. (2022) · International Journal of Science Engineering and Management · doi:10.36647/ijsem/09.09.a007 · Cited by 1
Staphylococcus aureus Vaccines
Daum, R. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35761-6.00055-9 · Cited by 1
Sahibzada, S. (2018) · Charles Sturt University Research Output (CRO) · Cited by 2
Methicillin-resistant Staphylococcus aureus (MRSA) : Prevention and fight against this pathogen
von Dach, E. (2017) · theses.fr (ABES) · doi:10.70675/670f56f3z833bz4428z94eez82aff6c73492 · Cited by 2
Staphylococcal and Enterococcal Infections
Graber, C. J., & Schaberg, D. R. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-534-7_21
“The patients in the emergency department study were relatively young (median age 39 years), suggesting that the impact of CA-MRSA epidemic on older individuals is less than that of younger individuals (8) . Another study that examined the annual incidence of MRSA disease across nine of the 10 medical centers and their…”
BackgroundSelf-citationEpidemiology of Community‐Associated Staphylococcus Aureus Infections
Gorwitz, R. J., & Jernigan, J. A. (2009) · Wiley eBooks · doi:10.1002/9781444308464.ch13 · Cited by 3
Camperlengo, L. P. (2012) · California State University ScholarWorks (system-wide DSpace)
Staphylococcus aureus résistant à la méticilline en réanimation
Kouatchet, A., & Eveillard, M. (2012) · Réanimation · doi:10.1007/s13546-012-0497-2
“[80] et Purcell et Fergie [81] (< 1, 2, 4 %, < 1 % respectivement) [66].”
Community-Associated Methicillin-Resistant Staphylococcus Aureus and HIV
Rhee, Y., & Popovich, K. J. (2014) · Future Virology · doi:10.2217/fvl.14.31
Pediatric and Adult Patients from Hospitals in a Large California County
Hudson, L. O., Murphy, C. R., Spratt, B. G., Terpstra, L., Gombosev, A., Hannah, P., Alexander, R. C., Moore, D. F., & Huang, S. S. (2012)
Locke, T. (2013) · uO Research (University of Ottawa) · doi:10.20381/ruor-3210
CA‐MRSA Skin Infections: An Ounce of Prevention Is Worth a Pound of Cure
Girard, N. J. (2014) · AORN Journal · doi:10.1016/j.aorn.2014.02.016
Kim, J. D. (2013) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/25388
Phenotypic and Genotypic Investigation of Persistent Staphylococcus aureus Bacteraemia Isolates
Richards, R. (2015) · Figshare
Johnson, I. (2010) · Journal of International Crisis and Risk Communication Research
Mbandezi, Y. (2018) · University of the Western Cape Electronic Theses and Dissertations Repository (University of the Western Cape)
Sung, K., Gudeta, D. D., Park, M., Vagnone, P. S., Nawaz, M. S., Foley, S. L., & Khan, S. A. (2021) · Microbiology Resource Announcements · doi:10.1128/mra.00929-21
Jeong, D. (2015) · uO Research (University of Ottawa) · doi:10.20381/ruor-2859
“About 90% of the cases of infections caused by CA-MRSA are SSTIs, and about 90% of them are abscesses or cellulitis with purulent drainage (4,5,10,61).”
Background
Metadata
- Authors
- Liu, C., Graber, C. J., Karr, M., Diep, B. A., Basuino, L., Schwartz, B. S., Enright, M. C., O’Hanlon, S. J., Thomas, J. C., Perdreau‐Remington, F., Gordon, S., Gunthorpe, H., Jacobs, R., Jensen, P., Leoung, G., Rumack, J. S., & Chambers, H. F.
- Affiliations
- San Francisco General Hospital (US)
- Imperial College London (GB)
- California Pacific Medical Center (US)
- St. Mary's Medical Center (US)
- University of California, San Francisco (US)
- San Francisco VA Medical Center (US)
- Saint Francis Memorial Hospital (US)
- Seton Medical Center (US)
- Corresponding author
- Liu, Catherine
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-06
- Volume
- 46
- Issue
- 11
- Pages
- 1637-1646
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2098229782
- Cited by
- 205
- References
- 41
- Citations by year
- 2025: 3 · 2024: 1 · 2023: 5 · 2022: 5 · 2021: 4 · 2020: 6 · 2019: 5 · 2018: 5 · 2017: 10 · 2016: 5 · 2015: 17 · 2014: 13 · 2013: 21 · 2012: 28
- FWCI
- 16.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Kaiser Permanente
- Centers for Disease Control and Prevention
- U.S. Public Health Service (CCR923381)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Keywords
- methicillin-resistant Staphylococcus aureus, USA300 clone, molecular epidemiology, clonal composition, antibiotic susceptibility, tetracycline resistance, skin and soft tissue infections, San Francisco
- MeSH terms
- Adult, Female, Humans, Male, Population Surveillance, Prospective Studies, San Francisco, Staphylococcal Infections, Staphylococcal Skin Infections, Staphylococcus aureus, Methicillin Resistance, Community-Acquired Infections, Molecular Epidemiology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.